News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Bitcoin edged lower near $64,400 as traders awaited U.S. nonfarm payrolls that could shift interest-rate expectations.
  • Hopes for an Iranian deal to reopen the Strait of Hormuz faded after no agreement emerged.
  • Crypto miner Mara reported worse-than-expected second-quarter results, pressuring miner stocks.
  • Most major altcoins recorded modest moves amid a mixed weekly performance.
  • Disney reported Q3 revenue growth of 7% and announced a $9 billion buyback, supporting its valuation.
  • Analysts see Disney's forward earnings trading at low-teens multiples with roughly $8.3 billion in free cash flow, favoring a measured long.

Latest Articles

WeRide Inc. Files Its 2025 Annual Report on Form 20-F

WeRide Inc. Files Its 2025 Annual Report on Form 20-F

WeRide Inc., a pioneer in autonomous driving technology and the first publicly traded Robotaxi company, announced the filing of its 2025 annual report on Form 20-F with the SEC. The report covers their business operations, technology deployments in over 40 cities across multiple countries, and regulatory achievements including autonomous driving pe…

Mobilicom to Exhibit at Modern Day Marine 2026, Showcasing its Cybersecure Solutions Portfolio Amid Growing U.S. Department of War Platform Deployments

Mobilicom to Exhibit at Modern Day Marine 2026, Showcasing its Cybersecure Solutions Portfolio Amid Growing U.S. Department of War Platform Deployments

Mobilicom Limited will exhibit its advanced cybersecurity and drone communication products at Modern Day Marine 2026. The company highlighted a recent U.S. Department of War Program of Record win achieved by a Tier-1 customer using Mobilicom's technology, indicating potential for high-volume production and multi-year contracts. Mobilicom’s portfoli…

Buy the Panic: Microsoft Is Too Cheap After an Overdone Tech Sell-Off

Buy the Panic: Microsoft Is Too Cheap After an Overdone Tech Sell-Off

Microsoft plunged ~10.7% into the close and opened lower on 04/23/2026. The sell-off looks indiscriminate relative to Microsoft's cash generation, profitability, low leverage and stake in AI upside. This trade idea lays out an entry at $422.24, stop at $395.00 and a primary target of $500.00 for a mid-term swing (45 trading days) with clear risk co…

Dollar Loses Clear Direction as Markets Dampen War Fears

Dollar Loses Clear Direction as Markets Dampen War Fears

Bank of America research indicates the US dollar has shed its post-conflict momentum and entered a less predictable trading regime. After an initial war-driven spike, the dollar index has moved back toward its prior range as investors grow less reactive to geopolitical uncertainty. Elevated oil prices, resilient US data and stronger risk appetite a…

RBC Highlights Three Aerospace & Defense Names to Watch as Q1 Results Start

RBC Highlights Three Aerospace & Defense Names to Watch as Q1 Results Start

RBC Capital Markets is flagging three aerospace and defense manufacturers — Northrop Grumman, Raytheon Technologies and Safran — ahead of first-quarter earnings that begin on April 21. The firm expects strength in aerospace aftermarket and defense segments, tempered by potential headwinds from higher fuel costs, supply-chain uncertainty and timing …

Casey’s Expands Partnership with SoundHound AI, Leveraging Cutting-Edge AI Agents Across More Than 2600 Stores

Casey’s Expands Partnership with SoundHound AI, Leveraging Cutting-Edge AI Agents Across More Than 2600 Stores

SoundHound AI has renewed and expanded its partnership with Casey's, the third-largest convenience retailer in the U.S., deploying its AI-powered voice ordering agents across over 2,600 Casey's locations. This technology has already processed more than 21 million customer interactions, improving order accuracy, reducing missed orders during peak ti…

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel)

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel)

Alpha Tau Medical received FDA approval for an Investigational Device Exemption (IDE) supplement that expands its ongoing IMPACT clinical trial, evaluating Alpha DaRT therapy combined with gemcitabine/nab-paclitaxel chemotherapy in pancreatic cancer patients. This expansion increases the trial size from 30 to 40 patients, including those with local…

Chicken Tenders, but Make Them Loco

Chicken Tenders, but Make Them Loco

El Pollo Loco, a leading US fire-grilled chicken restaurant chain, announces the launch of Loco Tenders™—a new limited-time menu item featuring crispy chicken tenders in spicy and classic flavors with signature dipping sauces. This product innovation aims to leverage the brand’s expertise in chicken and attract both new and existing customers acros…

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial

Alpha Tau Medical Ltd. announced the successful treatment of the first patient in its European ACAPELLA clinical trial using Alpha DaRT combined with capecitabine for inoperable locally advanced pancreatic cancer. This trial complements ongoing U.S. studies as part of a global expansion strategy to improve outcomes in a cancer type with very limite…

Merlin and Remah International Group Announce Exclusive Teaming Agreement to Scope Autonomy Opportunities in the UAE

Merlin and Remah International Group Announce Exclusive Teaming Agreement to Scope Autonomy Opportunities in the UAE

Merlin, Inc., an aerospace and defense technology company listed on Nasdaq, announced an exclusive teaming agreement between its subsidiary Merlin Labs and UAE-based Remah International Group. The partnership aims to introduce Merlin's AI-powered autonomy capabilities for military and commercial flight systems in the UAE, addressing the region's ri…

Leidos Wins $617 Million U.S. Army Contract for IFPC Increment 2 Launchers

Leidos Wins $617 Million U.S. Army Contract for IFPC Increment 2 Launchers

Leidos has been awarded a $617 million contract by the U.S. Army to supply additional launchers for the Indirect Fire Protection Capability Increment 2 (IFPC Increment 2) ground-based air defense system. The award increases the company’s Army business to nearly $1.2 billion in orders and commits more than 100 launchers for delivery. The contract wi…

Micropolis Robotics Signs Engineering and Manufacturing Agreement with Leading Logistics and Trade Solutions Company, DP World, to Advance Intelligent Automation Solutions into its Operations

Micropolis Robotics Signs Engineering and Manufacturing Agreement with Leading Logistics and Trade Solutions Company, DP World, to Advance Intelligent Automation Solutions into its Operations

Micropolis Holding Company, a UAE-based developer of autonomous robotics and AI systems, announced an engineering and manufacturing agreement with DP World to jointly develop a container ascending system aimed at improving efficiency and safety in logistics operations. This collaboration marks Micropolis's expansion into maritime and industrial log…

Codexis to Report First Quarter 2026 Financial Results on May 7

Codexis to Report First Quarter 2026 Financial Results on May 7

Codexis, Inc., a provider of enzymatic solutions for therapeutics manufacturing, will release its Q1 2026 financial results on May 7, 2026, followed by a management conference call and webcast. The company develops proprietary enzyme technologies to improve pharmaceutical and nucleic acid manufacturing, with a focus on scalable enzymatic production…

Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis

Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis

Connect Biopharma Holdings Limited announced that the independent Data Monitoring Committee has completed its interim analysis of the Phase 2 Seabreeze STAT studies investigating rademikibart for acute exacerbations of asthma and COPD. The interim results showed no safety concerns and no recommendation to change sample sizes, allowing enrollment to…